# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-015989
Filing Date
2022-04-26
Accepted
2022-04-26 17:02:41
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | ny20003900x3_defa14a.htm | DEFA14A | 5876
2 |  | ny20003900x3_nc01.jpg | GRAPHIC | 627236
3 |  | ny20003900x3_nc02.jpg | GRAPHIC | 488682
| Complete submission text file | 0001140361-22-015989.txt |  | 1544221

Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-11460 | Film No.: 22855210
SIC: 2834 Pharmaceutical Preparations